Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc.

World Rank (Jan-05-2024)
19,932
Market Cap (Jan-05-2024)
0.135 Billion USD
World Rank (Jul-30-2023)
20,952
Market Cap (Jul-30-2023)
0.114 Billion USD
World Rank (Jan-07-2022)
17,015
Market Cap (Jan-07-2022)
0.284 Billion USD
World Rank (Jan-01-2021)
11,544
Market Cap (Jan-01-2021)
0.462 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
GLSI
Market Cap (Mar-08-2026)
0.32
Headquarters City/State
Texas
World Region
Americas
World Subregion
Northern America
Business Sector
Healthcare
Biopharmaceutical
Biotechnology
Company Website
GREENWICH LIFESCIENCES, INC.
Company Profile
Greenwich LifeSciences, Inc. is a Public Clinical Stage Biopharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients have previously undergone surgery. The headquarters is in USA.
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share